Mark Dudley
Company: InstilBio UK
Job title: Chief Scientific Officer
Seminars:
Outlining the Progress of TIL Therapies 10:00 am
Exploring the ability for T-cell receptor therapies to target intracellular targets Identifying optimal TCRs for tumor specific antigens while navigating HLA restrictions Comparing cell and bispecific modalities to pinpoint benefitsRead more
day: Cell Therapy Fundamentals Day